Literature DB >> 8831873

Sexual desire, erection, orgasm and ejaculatory functions and their importance to elderly Swedish men: a population-based study.

A R Helgason1, J Adolfsson, P Dickman, S Arver, M Fredrikson, M Göthberg, G Steineck.   

Abstract

Relevant information for clinical decision-making in a wide spectrum of diseases includes the extent to which sexual function is intact, how important it is to preserve sexual capacity and whether waning sexual function causes distress. Little information is available on elderly men. We aimed to obtain this basic information. Radiumhemmet's Scale of Sexual Function was posted to 435 randomly selected men aged 50-80 years. Assessments included sexual desire, erectile capacity, orgasm and ejaculation and to what extent waning sexual function distressed the men. The questions were answered anonymously. Information was obtained from 319 men (73%). Of these, 83% stated that sex was 'very important', 'important' or a 'spice to life'. Physiological potency for men aged 50-59, 60-69 and 70-80 amounted to 97%, 76% and 51% respectively. Among the oldest men (70-80 years), 46% reported orgasm at least once a month. Over 80% of all men who reported some level of erection stated that it was of importance to them to maintain the present level of erection stiffness. Most men who reported waning sexual function (compared with their youth) stated that this distressed them. Sex is important to elderly men. Even among the 70-80-year-olds, an intact sexual desire, erection and orgasm are common and it is considered important to preserve them. Sexual function should be considered in the clinical assessment of elderly men.

Entities:  

Mesh:

Year:  1996        PMID: 8831873     DOI: 10.1093/ageing/25.4.285

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  12 in total

Review 1.  Prostate cancer in the elderly.

Authors:  Hatzimouratidis Konstantinos
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Sexual activity, sexual dysfunction and associated help-seeking behaviours in middle-aged and older adults in Spain: a population survey.

Authors:  Edson D Moreira; Dale B Glasser; Clive Gingell
Journal:  World J Urol       Date:  2005-12-08       Impact factor: 4.226

3.  Sexual function in adolescent and young adult cancer survivors-a population-based study.

Authors:  Maria Olsson; Gunnar Steineck; Karin Enskär; Ulrica Wilderäng; Marianne Jarfelt
Journal:  J Cancer Surviv       Date:  2018-03-05       Impact factor: 4.442

4.  Sexual behaviour, sexual dysfunctions and related help seeking patterns in middle-aged and elderly Europeans: the global study of sexual attitudes and behaviors.

Authors:  Alfredo Nicolosi; Jacques Buvat; Dale B Glasser; Uwe Hartmann; Edward O Laumann; Clive Gingell
Journal:  World J Urol       Date:  2006-07-19       Impact factor: 4.226

Review 5.  Health-related quality-of-life assessments in patients with advanced cancer of the prostate.

Authors:  Jan Adolfsson
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 6.  Intraurethral alprostadil for erectile dysfunction: a review of the literature.

Authors:  Pierre Costa; Axel-Juerg Potempa
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

7.  Quality of life in sexually active men with symptomatic benign prostatic hyperplasia : effects of treatment.

Authors:  Mel P Daly
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

8.  Sexuality: desire, activity and intimacy in the elderly.

Authors:  Gurvinder Kalra; Alka Subramanyam; Charles Pinto
Journal:  Indian J Psychiatry       Date:  2011-10       Impact factor: 1.759

Review 9.  The Role of Sex Therapy in the Management of Patients with Parkinson's Disease.

Authors:  Gila Bronner; Amos D Korczyn
Journal:  Mov Disord Clin Pract       Date:  2017-11-16

10.  Markers for detection of prostate cancer.

Authors:  Raymond A Clarke; Horst J Schirra; James W Catto; Martin F Lavin; Robert A Gardiner
Journal:  Cancers (Basel)       Date:  2010-06-04       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.